nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—Lisinopril—systemic scleroderma	0.164	0.328	CbGbCtD
Nadolol—ABCB1—Captopril—systemic scleroderma	0.123	0.246	CbGbCtD
Nadolol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0968	0.194	CbGbCtD
Nadolol—ABCB1—Prednisone—systemic scleroderma	0.0774	0.155	CbGbCtD
Nadolol—ABCB1—Methotrexate—systemic scleroderma	0.0388	0.0776	CbGbCtD
Nadolol—Bradycardia—Lisinopril—systemic scleroderma	0.00112	0.00225	CcSEcCtD
Nadolol—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00222	CcSEcCtD
Nadolol—Dyspepsia—Mometasone—systemic scleroderma	0.00111	0.00222	CcSEcCtD
Nadolol—Flatulence—Leflunomide—systemic scleroderma	0.0011	0.0022	CcSEcCtD
Nadolol—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0022	CcSEcCtD
Nadolol—Hallucination—Lisinopril—systemic scleroderma	0.0011	0.0022	CcSEcCtD
Nadolol—Decreased appetite—Mometasone—systemic scleroderma	0.00109	0.00219	CcSEcCtD
Nadolol—Shock—Captopril—systemic scleroderma	0.00109	0.00218	CcSEcCtD
Nadolol—Fatigue—Mometasone—systemic scleroderma	0.00109	0.00217	CcSEcCtD
Nadolol—Alopecia—Mycophenolic acid—systemic scleroderma	0.00108	0.00216	CcSEcCtD
Nadolol—Pain—Mometasone—systemic scleroderma	0.00108	0.00215	CcSEcCtD
Nadolol—Depression—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00215	CcSEcCtD
Nadolol—Anorexia—Captopril—systemic scleroderma	0.00105	0.00211	CcSEcCtD
Nadolol—Vision blurred—Leflunomide—systemic scleroderma	0.00105	0.00211	CcSEcCtD
Nadolol—Flatulence—Mycophenolic acid—systemic scleroderma	0.00105	0.0021	CcSEcCtD
Nadolol—Asthenia—Pentoxifylline—systemic scleroderma	0.00105	0.0021	CcSEcCtD
Nadolol—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00209	CcSEcCtD
Nadolol—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00104	0.00209	CcSEcCtD
Nadolol—Hypotension—Captopril—systemic scleroderma	0.00103	0.00207	CcSEcCtD
Nadolol—Pruritus—Pentoxifylline—systemic scleroderma	0.00103	0.00207	CcSEcCtD
Nadolol—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00206	CcSEcCtD
Nadolol—Tinnitus—Lisinopril—systemic scleroderma	0.00103	0.00206	CcSEcCtD
Nadolol—Amnesia—Prednisone—systemic scleroderma	0.00101	0.00202	CcSEcCtD
Nadolol—Vision blurred—Mycophenolic acid—systemic scleroderma	0.001	0.00201	CcSEcCtD
Nadolol—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.001	0.00201	CcSEcCtD
Nadolol—Insomnia—Captopril—systemic scleroderma	0.001	0.002	CcSEcCtD
Nadolol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000999	0.002	CcSEcCtD
Nadolol—Body temperature increased—Mometasone—systemic scleroderma	0.000996	0.00199	CcSEcCtD
Nadolol—Paraesthesia—Captopril—systemic scleroderma	0.000993	0.00199	CcSEcCtD
Nadolol—Dyspnoea—Captopril—systemic scleroderma	0.000986	0.00197	CcSEcCtD
Nadolol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000984	0.00197	CcSEcCtD
Nadolol—Cough—Leflunomide—systemic scleroderma	0.000975	0.00195	CcSEcCtD
Nadolol—Alopecia—Lisinopril—systemic scleroderma	0.000975	0.00195	CcSEcCtD
Nadolol—Dyspepsia—Captopril—systemic scleroderma	0.000974	0.00195	CcSEcCtD
Nadolol—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00097	0.00194	CcSEcCtD
Nadolol—Cardiac failure—Prednisone—systemic scleroderma	0.00097	0.00194	CcSEcCtD
Nadolol—Lethargy—Prednisone—systemic scleroderma	0.000966	0.00193	CcSEcCtD
Nadolol—Dizziness—Pentoxifylline—systemic scleroderma	0.000965	0.00193	CcSEcCtD
Nadolol—Hypertension—Leflunomide—systemic scleroderma	0.000965	0.00193	CcSEcCtD
Nadolol—Decreased appetite—Captopril—systemic scleroderma	0.000962	0.00192	CcSEcCtD
Nadolol—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000961	0.00192	CcSEcCtD
Nadolol—Syncope—Mycophenolic acid—systemic scleroderma	0.000956	0.00191	CcSEcCtD
Nadolol—Fatigue—Captopril—systemic scleroderma	0.000954	0.00191	CcSEcCtD
Nadolol—Chest pain—Leflunomide—systemic scleroderma	0.000951	0.0019	CcSEcCtD
Nadolol—Constipation—Captopril—systemic scleroderma	0.000946	0.00189	CcSEcCtD
Nadolol—Flatulence—Lisinopril—systemic scleroderma	0.000946	0.00189	CcSEcCtD
Nadolol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000937	0.00187	CcSEcCtD
Nadolol—Affect lability—Prednisone—systemic scleroderma	0.000932	0.00186	CcSEcCtD
Nadolol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00186	CcSEcCtD
Nadolol—Dry mouth—Leflunomide—systemic scleroderma	0.00093	0.00186	CcSEcCtD
Nadolol—Cough—Mycophenolic acid—systemic scleroderma	0.00093	0.00186	CcSEcCtD
Nadolol—Vomiting—Pentoxifylline—systemic scleroderma	0.000928	0.00186	CcSEcCtD
Nadolol—Rash—Pentoxifylline—systemic scleroderma	0.00092	0.00184	CcSEcCtD
Nadolol—Hypertension—Mycophenolic acid—systemic scleroderma	0.00092	0.00184	CcSEcCtD
Nadolol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00092	0.00184	CcSEcCtD
Nadolol—Chest pain—Mycophenolic acid—systemic scleroderma	0.000907	0.00182	CcSEcCtD
Nadolol—Vision blurred—Lisinopril—systemic scleroderma	0.000905	0.00181	CcSEcCtD
Nadolol—Asthenia—Mometasone—systemic scleroderma	0.000904	0.00181	CcSEcCtD
Nadolol—Irritability—Prednisone—systemic scleroderma	0.000904	0.00181	CcSEcCtD
Nadolol—Hypotension—Azathioprine—systemic scleroderma	0.000902	0.0018	CcSEcCtD
Nadolol—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000901	0.0018	CcSEcCtD
Nadolol—Mood swings—Prednisone—systemic scleroderma	0.000897	0.00179	CcSEcCtD
Nadolol—Pruritus—Mometasone—systemic scleroderma	0.000891	0.00178	CcSEcCtD
Nadolol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000887	0.00178	CcSEcCtD
Nadolol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000881	0.00176	CcSEcCtD
Nadolol—Body temperature increased—Captopril—systemic scleroderma	0.000875	0.00175	CcSEcCtD
Nadolol—Oedema—Mycophenolic acid—systemic scleroderma	0.00087	0.00174	CcSEcCtD
Nadolol—Anorexia—Leflunomide—systemic scleroderma	0.000869	0.00174	CcSEcCtD
Nadolol—Dry skin—Prednisone—systemic scleroderma	0.000868	0.00174	CcSEcCtD
Nadolol—Nausea—Pentoxifylline—systemic scleroderma	0.000867	0.00173	CcSEcCtD
Nadolol—Diarrhoea—Mometasone—systemic scleroderma	0.000862	0.00172	CcSEcCtD
Nadolol—Syncope—Lisinopril—systemic scleroderma	0.000861	0.00172	CcSEcCtD
Nadolol—Shock—Mycophenolic acid—systemic scleroderma	0.000856	0.00171	CcSEcCtD
Nadolol—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000854	0.00171	CcSEcCtD
Nadolol—Hypotension—Leflunomide—systemic scleroderma	0.000852	0.0017	CcSEcCtD
Nadolol—Loss of consciousness—Lisinopril—systemic scleroderma	0.000844	0.00169	CcSEcCtD
Nadolol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000841	0.00168	CcSEcCtD
Nadolol—Cough—Lisinopril—systemic scleroderma	0.000838	0.00168	CcSEcCtD
Nadolol—Visual disturbance—Methotrexate—systemic scleroderma	0.000835	0.00167	CcSEcCtD
Nadolol—Anorexia—Mycophenolic acid—systemic scleroderma	0.000829	0.00166	CcSEcCtD
Nadolol—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000829	0.00166	CcSEcCtD
Nadolol—Insomnia—Leflunomide—systemic scleroderma	0.000825	0.00165	CcSEcCtD
Nadolol—Abdominal distension—Prednisone—systemic scleroderma	0.000824	0.00165	CcSEcCtD
Nadolol—Paraesthesia—Leflunomide—systemic scleroderma	0.000819	0.00164	CcSEcCtD
Nadolol—Chest pain—Lisinopril—systemic scleroderma	0.000817	0.00163	CcSEcCtD
Nadolol—Dyspnoea—Leflunomide—systemic scleroderma	0.000813	0.00163	CcSEcCtD
Nadolol—Hypotension—Mycophenolic acid—systemic scleroderma	0.000813	0.00163	CcSEcCtD
Nadolol—Lethargy—Methotrexate—systemic scleroderma	0.000807	0.00162	CcSEcCtD
Nadolol—Dyspepsia—Leflunomide—systemic scleroderma	0.000803	0.00161	CcSEcCtD
Nadolol—Vomiting—Mometasone—systemic scleroderma	0.000801	0.0016	CcSEcCtD
Nadolol—Dry mouth—Lisinopril—systemic scleroderma	0.000799	0.0016	CcSEcCtD
Nadolol—Rash—Mometasone—systemic scleroderma	0.000794	0.00159	CcSEcCtD
Nadolol—Asthenia—Captopril—systemic scleroderma	0.000794	0.00159	CcSEcCtD
Nadolol—Dermatitis—Mometasone—systemic scleroderma	0.000793	0.00159	CcSEcCtD
Nadolol—Decreased appetite—Leflunomide—systemic scleroderma	0.000793	0.00159	CcSEcCtD
Nadolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000787	0.00157	CcSEcCtD
Nadolol—Fatigue—Leflunomide—systemic scleroderma	0.000786	0.00157	CcSEcCtD
Nadolol—Oedema—Lisinopril—systemic scleroderma	0.000784	0.00157	CcSEcCtD
Nadolol—Pruritus—Captopril—systemic scleroderma	0.000783	0.00157	CcSEcCtD
Nadolol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000781	0.00156	CcSEcCtD
Nadolol—Pain—Leflunomide—systemic scleroderma	0.00078	0.00156	CcSEcCtD
Nadolol—Constipation—Leflunomide—systemic scleroderma	0.00078	0.00156	CcSEcCtD
Nadolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000776	0.00155	CcSEcCtD
Nadolol—Shock—Lisinopril—systemic scleroderma	0.000771	0.00154	CcSEcCtD
Nadolol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000766	0.00153	CcSEcCtD
Nadolol—Body temperature increased—Azathioprine—systemic scleroderma	0.000763	0.00153	CcSEcCtD
Nadolol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000757	0.00152	CcSEcCtD
Nadolol—Diarrhoea—Captopril—systemic scleroderma	0.000757	0.00151	CcSEcCtD
Nadolol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000756	0.00151	CcSEcCtD
Nadolol—Irritability—Methotrexate—systemic scleroderma	0.000755	0.00151	CcSEcCtD
Nadolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000754	0.00151	CcSEcCtD
Nadolol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000754	0.00151	CcSEcCtD
Nadolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00075	0.0015	CcSEcCtD
Nadolol—Mood swings—Methotrexate—systemic scleroderma	0.00075	0.0015	CcSEcCtD
Nadolol—Nausea—Mometasone—systemic scleroderma	0.000748	0.0015	CcSEcCtD
Nadolol—Anorexia—Lisinopril—systemic scleroderma	0.000747	0.00149	CcSEcCtD
Nadolol—Weight increased—Prednisone—systemic scleroderma	0.000745	0.00149	CcSEcCtD
Nadolol—Pain—Mycophenolic acid—systemic scleroderma	0.000744	0.00149	CcSEcCtD
Nadolol—Constipation—Mycophenolic acid—systemic scleroderma	0.000744	0.00149	CcSEcCtD
Nadolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000739	0.00148	CcSEcCtD
Nadolol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000734	0.00147	CcSEcCtD
Nadolol—Hypotension—Lisinopril—systemic scleroderma	0.000732	0.00146	CcSEcCtD
Nadolol—Dizziness—Captopril—systemic scleroderma	0.000732	0.00146	CcSEcCtD
Nadolol—Depression—Prednisone—systemic scleroderma	0.000728	0.00146	CcSEcCtD
Nadolol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00145	CcSEcCtD
Nadolol—Body temperature increased—Leflunomide—systemic scleroderma	0.000721	0.00144	CcSEcCtD
Nadolol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00143	CcSEcCtD
Nadolol—Insomnia—Lisinopril—systemic scleroderma	0.000709	0.00142	CcSEcCtD
Nadolol—Paraesthesia—Lisinopril—systemic scleroderma	0.000704	0.00141	CcSEcCtD
Nadolol—Vomiting—Captopril—systemic scleroderma	0.000703	0.00141	CcSEcCtD
Nadolol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.0007	0.0014	CcSEcCtD
Nadolol—Dyspnoea—Lisinopril—systemic scleroderma	0.000699	0.0014	CcSEcCtD
Nadolol—Rash—Captopril—systemic scleroderma	0.000698	0.0014	CcSEcCtD
Nadolol—Dermatitis—Captopril—systemic scleroderma	0.000697	0.00139	CcSEcCtD
Nadolol—Dyspepsia—Lisinopril—systemic scleroderma	0.00069	0.00138	CcSEcCtD
Nadolol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000688	0.00138	CcSEcCtD
Nadolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00137	CcSEcCtD
Nadolol—Decreased appetite—Lisinopril—systemic scleroderma	0.000681	0.00136	CcSEcCtD
Nadolol—Fatigue—Lisinopril—systemic scleroderma	0.000676	0.00135	CcSEcCtD
Nadolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000675	0.00135	CcSEcCtD
Nadolol—Pain—Lisinopril—systemic scleroderma	0.00067	0.00134	CcSEcCtD
Nadolol—Constipation—Lisinopril—systemic scleroderma	0.00067	0.00134	CcSEcCtD
Nadolol—Bradycardia—Prednisone—systemic scleroderma	0.000667	0.00133	CcSEcCtD
Nadolol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00133	CcSEcCtD
Nadolol—Diarrhoea—Azathioprine—systemic scleroderma	0.000661	0.00132	CcSEcCtD
Nadolol—Nausea—Captopril—systemic scleroderma	0.000657	0.00131	CcSEcCtD
Nadolol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000656	0.00131	CcSEcCtD
Nadolol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000654	0.00131	CcSEcCtD
Nadolol—Asthenia—Leflunomide—systemic scleroderma	0.000654	0.00131	CcSEcCtD
Nadolol—Hallucination—Prednisone—systemic scleroderma	0.000652	0.0013	CcSEcCtD
Nadolol—Pruritus—Leflunomide—systemic scleroderma	0.000645	0.00129	CcSEcCtD
Nadolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000641	0.00128	CcSEcCtD
Nadolol—Dizziness—Azathioprine—systemic scleroderma	0.000638	0.00128	CcSEcCtD
Nadolol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00063	0.00126	CcSEcCtD
Nadolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000624	0.00125	CcSEcCtD
Nadolol—Diarrhoea—Leflunomide—systemic scleroderma	0.000624	0.00125	CcSEcCtD
Nadolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000621	0.00124	CcSEcCtD
Nadolol—Body temperature increased—Lisinopril—systemic scleroderma	0.000619	0.00124	CcSEcCtD
Nadolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000616	0.00123	CcSEcCtD
Nadolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000615	0.00123	CcSEcCtD
Nadolol—Vomiting—Azathioprine—systemic scleroderma	0.000614	0.00123	CcSEcCtD
Nadolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000612	0.00122	CcSEcCtD
Nadolol—Rash—Azathioprine—systemic scleroderma	0.000609	0.00122	CcSEcCtD
Nadolol—Dermatitis—Azathioprine—systemic scleroderma	0.000608	0.00122	CcSEcCtD
Nadolol—Depression—Methotrexate—systemic scleroderma	0.000608	0.00122	CcSEcCtD
Nadolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000604	0.00121	CcSEcCtD
Nadolol—Dizziness—Leflunomide—systemic scleroderma	0.000603	0.00121	CcSEcCtD
Nadolol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000597	0.00119	CcSEcCtD
Nadolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000595	0.00119	CcSEcCtD
Nadolol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000593	0.00119	CcSEcCtD
Nadolol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00117	CcSEcCtD
Nadolol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00117	CcSEcCtD
Nadolol—Sweating—Methotrexate—systemic scleroderma	0.000585	0.00117	CcSEcCtD
Nadolol—Vomiting—Leflunomide—systemic scleroderma	0.00058	0.00116	CcSEcCtD
Nadolol—Alopecia—Prednisone—systemic scleroderma	0.000579	0.00116	CcSEcCtD
Nadolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000575	0.00115	CcSEcCtD
Nadolol—Rash—Leflunomide—systemic scleroderma	0.000575	0.00115	CcSEcCtD
Nadolol—Dermatitis—Leflunomide—systemic scleroderma	0.000574	0.00115	CcSEcCtD
Nadolol—Nausea—Azathioprine—systemic scleroderma	0.000574	0.00115	CcSEcCtD
Nadolol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000569	0.00114	CcSEcCtD
Nadolol—Asthenia—Lisinopril—systemic scleroderma	0.000562	0.00112	CcSEcCtD
Nadolol—Pruritus—Lisinopril—systemic scleroderma	0.000554	0.00111	CcSEcCtD
Nadolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000553	0.00111	CcSEcCtD
Nadolol—Rash—Mycophenolic acid—systemic scleroderma	0.000548	0.0011	CcSEcCtD
Nadolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000548	0.0011	CcSEcCtD
Nadolol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000543	0.00109	CcSEcCtD
Nadolol—Nausea—Leflunomide—systemic scleroderma	0.000542	0.00108	CcSEcCtD
Nadolol—Vision blurred—Prednisone—systemic scleroderma	0.000537	0.00107	CcSEcCtD
Nadolol—Diarrhoea—Lisinopril—systemic scleroderma	0.000536	0.00107	CcSEcCtD
Nadolol—Visual impairment—Methotrexate—systemic scleroderma	0.000528	0.00106	CcSEcCtD
Nadolol—Dizziness—Lisinopril—systemic scleroderma	0.000518	0.00104	CcSEcCtD
Nadolol—Nausea—Mycophenolic acid—systemic scleroderma	0.000517	0.00103	CcSEcCtD
Nadolol—Syncope—Prednisone—systemic scleroderma	0.000511	0.00102	CcSEcCtD
Nadolol—Tinnitus—Methotrexate—systemic scleroderma	0.00051	0.00102	CcSEcCtD
Nadolol—Loss of consciousness—Prednisone—systemic scleroderma	0.000501	0.001	CcSEcCtD
Nadolol—Vomiting—Lisinopril—systemic scleroderma	0.000498	0.000997	CcSEcCtD
Nadolol—Rash—Lisinopril—systemic scleroderma	0.000494	0.000988	CcSEcCtD
Nadolol—Dermatitis—Lisinopril—systemic scleroderma	0.000494	0.000987	CcSEcCtD
Nadolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000985	CcSEcCtD
Nadolol—Hypertension—Prednisone—systemic scleroderma	0.000492	0.000985	CcSEcCtD
Nadolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000972	CcSEcCtD
Nadolol—Alopecia—Methotrexate—systemic scleroderma	0.000484	0.000968	CcSEcCtD
Nadolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00094	CcSEcCtD
Nadolol—Nausea—Lisinopril—systemic scleroderma	0.000465	0.000931	CcSEcCtD
Nadolol—Oedema—Prednisone—systemic scleroderma	0.000465	0.000931	CcSEcCtD
Nadolol—Shock—Prednisone—systemic scleroderma	0.000458	0.000916	CcSEcCtD
Nadolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000908	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisone—systemic scleroderma	0.00045	0.0009	CcSEcCtD
Nadolol—Vision blurred—Methotrexate—systemic scleroderma	0.000449	0.000898	CcSEcCtD
Nadolol—Anorexia—Prednisone—systemic scleroderma	0.000444	0.000887	CcSEcCtD
Nadolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000873	CcSEcCtD
Nadolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000866	CcSEcCtD
Nadolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000865	CcSEcCtD
Nadolol—Insomnia—Prednisone—systemic scleroderma	0.000421	0.000842	CcSEcCtD
Nadolol—Paraesthesia—Prednisone—systemic scleroderma	0.000418	0.000836	CcSEcCtD
Nadolol—Cough—Methotrexate—systemic scleroderma	0.000416	0.000832	CcSEcCtD
Nadolol—Dyspepsia—Prednisone—systemic scleroderma	0.00041	0.000819	CcSEcCtD
Nadolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000816	CcSEcCtD
Nadolol—Chest pain—Methotrexate—systemic scleroderma	0.000406	0.000812	CcSEcCtD
Nadolol—Decreased appetite—Prednisone—systemic scleroderma	0.000405	0.000809	CcSEcCtD
Nadolol—Fatigue—Prednisone—systemic scleroderma	0.000401	0.000803	CcSEcCtD
Nadolol—Constipation—Prednisone—systemic scleroderma	0.000398	0.000796	CcSEcCtD
Nadolol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000376	0.000752	CcSEcCtD
Nadolol—Anorexia—Methotrexate—systemic scleroderma	0.000371	0.000742	CcSEcCtD
Nadolol—Body temperature increased—Prednisone—systemic scleroderma	0.000368	0.000736	CcSEcCtD
Nadolol—Hypotension—Methotrexate—systemic scleroderma	0.000363	0.000727	CcSEcCtD
Nadolol—Insomnia—Methotrexate—systemic scleroderma	0.000352	0.000704	CcSEcCtD
Nadolol—Paraesthesia—Methotrexate—systemic scleroderma	0.000349	0.000699	CcSEcCtD
Nadolol—Dyspnoea—Methotrexate—systemic scleroderma	0.000347	0.000694	CcSEcCtD
Nadolol—Dyspepsia—Methotrexate—systemic scleroderma	0.000342	0.000685	CcSEcCtD
Nadolol—Decreased appetite—Methotrexate—systemic scleroderma	0.000338	0.000676	CcSEcCtD
Nadolol—Fatigue—Methotrexate—systemic scleroderma	0.000335	0.000671	CcSEcCtD
Nadolol—Asthenia—Prednisone—systemic scleroderma	0.000334	0.000668	CcSEcCtD
Nadolol—Pain—Methotrexate—systemic scleroderma	0.000333	0.000665	CcSEcCtD
Nadolol—Pruritus—Prednisone—systemic scleroderma	0.000329	0.000659	CcSEcCtD
Nadolol—Diarrhoea—Prednisone—systemic scleroderma	0.000318	0.000637	CcSEcCtD
Nadolol—Dizziness—Prednisone—systemic scleroderma	0.000308	0.000616	CcSEcCtD
Nadolol—Body temperature increased—Methotrexate—systemic scleroderma	0.000307	0.000615	CcSEcCtD
Nadolol—Vomiting—Prednisone—systemic scleroderma	0.000296	0.000592	CcSEcCtD
Nadolol—Rash—Prednisone—systemic scleroderma	0.000293	0.000587	CcSEcCtD
Nadolol—Dermatitis—Prednisone—systemic scleroderma	0.000293	0.000586	CcSEcCtD
Nadolol—Asthenia—Methotrexate—systemic scleroderma	0.000279	0.000558	CcSEcCtD
Nadolol—Nausea—Prednisone—systemic scleroderma	0.000276	0.000553	CcSEcCtD
Nadolol—Pruritus—Methotrexate—systemic scleroderma	0.000275	0.00055	CcSEcCtD
Nadolol—Diarrhoea—Methotrexate—systemic scleroderma	0.000266	0.000532	CcSEcCtD
Nadolol—Dizziness—Methotrexate—systemic scleroderma	0.000257	0.000514	CcSEcCtD
Nadolol—Vomiting—Methotrexate—systemic scleroderma	0.000247	0.000495	CcSEcCtD
Nadolol—Rash—Methotrexate—systemic scleroderma	0.000245	0.000491	CcSEcCtD
Nadolol—Dermatitis—Methotrexate—systemic scleroderma	0.000245	0.00049	CcSEcCtD
Nadolol—Nausea—Methotrexate—systemic scleroderma	0.000231	0.000462	CcSEcCtD
